HSBC Holdings’s IDEAYA Biosciences IDYA Stock Holding History

HSBC Holdings’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$645K	Buy	19,258 +725	+4%	+$24.3K	﹤0.01%	2093
2025 Q4	$644K	Sell	18,533 -1,873	-9%	-$59.7K	﹤0.01%	2180
2025 Q3	$560K	Sell	20,406 -17,284	-46%	-$418K	﹤0.01%	2045
2025 Q2	$804K	Sell	37,690 -47,301	-56%	-$908K	﹤0.01%	1905
2025 Q1	$1.36M	Buy	84,991 +46,301	+120%	+$986K	﹤0.01%	1611
2024 Q4	$980K	Buy	38,690 +15,465	+67%	+$438K	﹤0.01%	1814
2024 Q3	$732K	Buy	23,225 +7,956	+52%	+$302K	﹤0.01%	1831
2024 Q2	$528K	Buy	15,269 +6,789	+80%	+$269K	﹤0.01%	1943
2024 Q1	$372K	Sell	8,480 -2,693	-24%	-$116K	﹤0.01%	2278
2023 Q4	$403K	Sell	11,173 -2,226	-17%	-$66.4K	﹤0.01%	2146
2023 Q3	$359K	Buy	+13,399	New	+$340K	﹤0.01%	2123
2022 Q2	–	Sell	-11,787	Closed	-$133K	–	3341
2022 Q1	$133K	Buy	+11,787	New	+$174K	﹤0.01%	3080
2019 Q4	–	Sell	-10,316	Closed	-$93K	–	3108
2019 Q3	$93K	Buy	+10,316	New	+$78.7K	﹤0.01%	2985

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HSBC Holdings's IDYA Position: Q1 2026 in Review

HSBC Holdings increased its IDEAYA Biosciences (IDYA) stake by 3.9% in Q1 2026, buying an estimated $24.3K and bringing the position to 19,258 shares worth $645K. The position accounts for ﹤0.01% of the portfolio, ranked #2093.

HSBC Holdings first reported a position in IDYA in Q3 2019 and has held it in 13 quarters since. The position peaked at $1.36M in Q1 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

HSBC Holdings held 19,258 shares of IDEAYA Biosciences worth $645K as of Q1 2026.
HSBC Holdings bought 725 IDEAYA Biosciences shares in Q1 2026, an estimated $24.3K.
IDEAYA Biosciences made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2093 holding.
HSBC Holdings first reported a position in IDEAYA Biosciences in Q3 2019 and has held it in 13 quarters since.
HSBC Holdings's IDEAYA Biosciences position peaked at $1.36M in Q1 2025.
253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.